Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore G Karrison

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Cancer|February 20, 2020
A randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinomaSara E Kochanny, Francis P Worden, Douglas R Adkins, et al.
Haematologica|July 29, 2021
Phase I/II clinical trial of temsirolimus and lenalidomide in patients with relapsed and refractory lymphomasAjay Major, Justin Kline, Theodore G Karrison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2013
Evaluation of food effect on pharmacokinetics of vismodegib in advanced solid tumor patientsManish R Sharma, Theodore G Karrison, Bethany Kell, et al.
The Journal of Clinical Investigation|May 15, 2023
Partial tumor irradiation plus pembrolizumab in treating large advanced solid tumor metastasesMark C Korpics, Benjamin E Onderdonk, Rebekah E Dadey, et al.
BMC Cancer|January 7, 2014
Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small cell lung cancerMichael L Maitland, Matthew R Levine, Mario E Lacouture, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2019
Clinical Assessment of 5-Fluorouracil/Leucovorin, Nab-Paclitaxel, and Irinotecan (FOLFIRABRAX) in Untreated Patients with Gastrointestinal Cancer Using <i>UGT1A1</i> Genotype-Guided DosingSmita S Joshi, Daniel V T Catenacci, Theodore G Karrison, et al.
Neuro-Oncology Advances|February 29, 2024
A multi-institutional phase I study of acetazolamide with temozolomide in adults with newly diagnosed <i>MGMT</i>-methylated malignant gliomaRiley K Driscoll, Sean B Lyne, David J Voce, et al.
The Lancet. Oncology|February 10, 2009
Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II studyEzra E W Cohen, Darren W Davis, Theodore G Karrison, et al.
Cancer|June 6, 2022
Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual diseaseAmi V Desai, Mark A Applebaum, Theodore G Karrison, et al.
Blood Advances|February 20, 2020
A phase 1 study of azacitidine with high-dose cytarabine and mitoxantrone in high-risk acute myeloid leukemiaKirk E Cahill, Yasmin H Karimi, Theodore G Karrison, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Cancer|February 20, 2020
A randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinomaSara E Kochanny, Francis P Worden, Douglas R Adkins, et al.
Haematologica|July 29, 2021
Phase I/II clinical trial of temsirolimus and lenalidomide in patients with relapsed and refractory lymphomasAjay Major, Justin Kline, Theodore G Karrison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2013
Evaluation of food effect on pharmacokinetics of vismodegib in advanced solid tumor patientsManish R Sharma, Theodore G Karrison, Bethany Kell, et al.
The Journal of Clinical Investigation|May 15, 2023
Partial tumor irradiation plus pembrolizumab in treating large advanced solid tumor metastasesMark C Korpics, Benjamin E Onderdonk, Rebekah E Dadey, et al.
BMC Cancer|January 7, 2014
Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small cell lung cancerMichael L Maitland, Matthew R Levine, Mario E Lacouture, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2019
Clinical Assessment of 5-Fluorouracil/Leucovorin, Nab-Paclitaxel, and Irinotecan (FOLFIRABRAX) in Untreated Patients with Gastrointestinal Cancer Using <i>UGT1A1</i> Genotype-Guided DosingSmita S Joshi, Daniel V T Catenacci, Theodore G Karrison, et al.
Neuro-Oncology Advances|February 29, 2024
A multi-institutional phase I study of acetazolamide with temozolomide in adults with newly diagnosed <i>MGMT</i>-methylated malignant gliomaRiley K Driscoll, Sean B Lyne, David J Voce, et al.
The Lancet. Oncology|February 10, 2009
Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II studyEzra E W Cohen, Darren W Davis, Theodore G Karrison, et al.
Cancer|June 6, 2022
Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual diseaseAmi V Desai, Mark A Applebaum, Theodore G Karrison, et al.
Blood Advances|February 20, 2020
A phase 1 study of azacitidine with high-dose cytarabine and mitoxantrone in high-risk acute myeloid leukemiaKirk E Cahill, Yasmin H Karimi, Theodore G Karrison, et al.
Pageof 7